Alessandra, T., Ester, P., Alessandra Dal, M., Milena, L., Gabriella De, C., Giuseppe, R., et al. (2018). Genes and Pathways Dysregulated by Nilotinib Treatment in Bone Marrow CD34+/Lin- Cells of Patients with Chronic-Phase Chronic Myeloid Leukaemia. EUROPEAN MEDICAL JOURNAL. HEMATOLOGY, 6(1), 52-54.

Genes and Pathways Dysregulated by Nilotinib Treatment in Bone Marrow CD34+/Lin- Cells of Patients with Chronic-Phase Chronic Myeloid Leukaemia

Cairoli Roberto
Ultimo
2018

Articolo in rivista - Articolo scientifico
Bone marrow CD34+/Lin- cells, chronic myeloid leukaemia (CML), genes and pathways, nilotinib
English
2018
6
1
52
54
open
Alessandra, T., Ester, P., Alessandra Dal, M., Milena, L., Gabriella De, C., Giuseppe, R., et al. (2018). Genes and Pathways Dysregulated by Nilotinib Treatment in Bone Marrow CD34+/Lin- Cells of Patients with Chronic-Phase Chronic Myeloid Leukaemia. EUROPEAN MEDICAL JOURNAL. HEMATOLOGY, 6(1), 52-54.
File in questo prodotto:
File Dimensione Formato  
Trojani-2018-Eur Med J Hematol-VoR.pdf

accesso aperto

Descrizione: Article
Tipologia di allegato: Publisher’s Version (Version of Record, VoR)
Licenza: Creative Commons
Dimensione 173.12 kB
Formato Adobe PDF
173.12 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/404024
Citazioni
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
Social impact